Article
Establishment of a CIMP-associated prognostic model for bladder cancer
2026-03-23
Abstract excerpt
<title>Abstract</title> <p> Background Bladder cancer (BLCA) is the leading cause of cancer-related morbidity and mortality among urological cancers, with a 5-year survival rate of 30–50% for MIBC. While DNA methyltransferase inhibitors may activate the anti-tumor immune response, the role of CpG island methylator phenotype (CIMP) in BLCA remains unclear. It is urgent to identify valuable risk models to assist...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9805a83c-4f04-5cd4-b4f9-4cd8c99572c7
- DOI
- 10.21203/rs.3.rs-8947218/v1
